These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1682345)

  • 21. Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals.
    Benson EM; Clarkson J; Law M; Marshall P; Kelleher AD; Smith DE; Patou G; Stewart GJ; Cooper DA; French RA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):105-13. PubMed ID: 10029243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
    Muñoz-Fernández MA; Navarro J; Montes MG; Cosín J; Zabay JM; Fernández-Cruz E
    J Clin Microbiol; 1996 Feb; 34(2):404-8. PubMed ID: 8789024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
    JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction.
    Schüpbach J; Flepp M; Pontelli D; Tomasik Z; Lüthy R; Böni J
    AIDS; 1996 Sep; 10(10):1085-90. PubMed ID: 8874624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.
    Anderson DJ; O'Brien TR; Politch JA; Martinez A; Seage GR; Padian N; Horsburgh CR; Mayer KH
    JAMA; 1992 May; 267(20):2769-74. PubMed ID: 1349654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
    J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a quantitative RNA PCR assay for HIV-1 in human plasma.
    Wathen LK; Crampton DJ; Patel RK; Nuorala KW; Poppe SM; Dueweke TJ; Re' KA; Krieger KS; Tarpley WG
    J Clin Lab Anal; 1996; 10(5):262-8. PubMed ID: 8887005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy.
    Bush CE; Donovan RM; Smereck SM; Strang D; Markowitz N; Saravolatz LD
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):183-7. PubMed ID: 8096146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
    Science; 1993 Mar; 259(5102):1749-54. PubMed ID: 8096089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
    Collier AC; Bozzette S; Coombs RW; Causey DM; Schoenfeld DA; Spector SA; Pettinelli CB; Davies G; Richman DD; Leedom JM
    N Engl J Med; 1990 Oct; 323(15):1015-21. PubMed ID: 1977080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
    Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
    Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of a qualitative reverse-transcriptase nested polymerase chain reaction protocol for same-day viral validation of human immunodeficiency virus type 1 ribonucleic acid in processed semen.
    Lesage B; Vannin AS; Emiliani S; Debaisieux L; Englert Y; Liesnard C
    Fertil Steril; 2006 Jul; 86(1):121-8. PubMed ID: 16756977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    Cao Y; Qin L; Zhang L; Safrit J; Ho DD
    N Engl J Med; 1995 Jan; 332(4):201-8. PubMed ID: 7808485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct detection of HIV RNA expression in seropositive subjects.
    Hart C; Schochetman G; Spira T; Lifson A; Moore J; Galphin J; Sninsky J; Ou CY
    Lancet; 1988 Sep; 2(8611):596-9. PubMed ID: 2900979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in zidovudine prescription since 1987 in AIDS-free HIV-positive French patients attending university hospitals.
    Guiguet M; Mary M; Costagliola D; Armengaud M; Cartier F; Micoud M; Mouton Y; Sobesky G; Valleron AJ
    AIDS; 1992 Nov; 6(11):1405-6. PubMed ID: 1361751
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of the human immunodeficiency virus virion as a universal standard for viral RNA quantitation by reverse transcription-linked polymerase chain reaction.
    Lu W; Andrieu JM
    J Infect Dis; 1993 Jun; 167(6):1498-9. PubMed ID: 8501347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.